Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Methyl Beta Cyclodextrin | Methyl Beta Cyclodextrin. Product ID: PE-0019. Molecular formula: C42H70-NO35·(CH3)n. Category: Emulsifier Excipients. Product Keywords: Pharmaceutical Excipients; Emulsifier Excipients; Methyl Beta Cyclodextrin; PE-0019; C42H70-NO35·(CH3)n. Appearance: White powder. Sample Provided: Yes. Standard: In-house standard. Grade: Enterprise grade. Purity: ≥98%. Solubility: Very soluble in water and methanol,easily soluble in ethanol and ethylene glycol,almost insoluble in cyclohexane and ethyl acetate. |  |
| 2,6-Dimethyl-β-cyclodextrin | 2,6-Dimethyl-β-cyclodextrin is a β-cyclodextrin derivative with enhanced water solubility. It can be used as a solubilizer and stabilizer in pharmaceutical preparations. It can effectively dissolve lipophilic drugs such as steroid hormones, vitamins A, E and K to improve the solubility and bioavailability of weakly hydrophilic drug compounds. Synonyms: 2,6-Di-O-methyl-beta-cyclodextrin; Heptakis(2,6-di-O-methyl)-beta-cyclodextrin. CAS No. 51166-71-3. Molecular formula: C56H98O35. Mole weight: 1331.36. |  |
| 2,6-Di-O-methyl-β-cyclodextrin | 2,6-Di-O-methyl-β-cyclodextrin. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 2,6-Di-O-methyl-beta-cyclodextrin. Product Category: Promotional Products. Appearance: solid. CAS No. 51166-71-3. Molecular formula: C56H98O35. Mole weight: 1331.36. Purity: 95+%. Product ID: ACM51166713-3. Alfa Chemistry ISO 9001:2015 Certified. |  |
| 2,6-Di-O-methyl-beta-cyclodextrin | 2,6-Di-O-methyl-beta-cyclodextrin. Group: Macrocycles. Alternative Names: DIMETHYL BETA-CYCLODEXTRIN; DIMEB; HEPTAKIS(2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN; 2,6-DI-O-METHYL-BETA-CYCLODEXTRIN; 6(supa), 6(supb), 6(supc), 6(supd), 6(supe), 6(supf), 6(supg)-tetradeca-o-g; beta-cyclodextrin, 2(supa), 2(supb), 2(supc), 2(supd), 2(supe), 2(supf), 2(sup; heptakis(2,6-o-dimethyl)beta-cyclodextrin; HEPTAKIS(2,6-DI-O-METHYL)-B-*CYCLODEXTRI N. CAS No. 51166-71-3. Molecular formula: 1331.36. Mole weight: C56< / sub>H98< / sub>O35< / sub>. |  |
| Heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin | Heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin. Group: Macrocycles. CAS No. 55216-11-0. Product ID: (1R, 3R, 5R, 6R, 8R, 10R, 11R, 13R, 15R, 16R, 18R, 20R, 21R, 23R, 25R, 26R, 28R, 30R, 31R, 33R, 35R, 36S, 37R, 38S, 39R, 40S, 41R, 42S, 43R, 44S, 45R, 46S, 47R, 48S, 49R)-36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49-tetradecamethoxy-5, 10, 15, 20, 25, 30, 35-heptakis(methoxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34-tetradecaoxaoctacyclo[31.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31]nonatetracontane. Molecular formula: 1429.5g/mol. Mole weight: C63H112O35. COCC1C2C (C (C (O1) OC3C (OC (C (C3OC) OC) OC4C (OC (C (C4OC) OC) OC5C (OC (C (C5OC) OC) OC6C (OC (C (C6OC) OC) OC7C (OC (C (C7OC) OC) OC8C (OC (O2) C (C8OC) OC) COC) COC) COC) COC) COC) COC) OC) OC. InChI=1S / C63H112O35 / c1-64-22-29-36-43 (71-8) 50 (78-15) 57 (85-29) 93-37-30 (23-65-2) 87-59 (52 (80-17) 44 (37) 72-9) 95-39-32 (25-67-4) 89-61 (54 (82-19) 46 (39) 74-11) 97-41-34 (27-69-6) 91-63 (56 (84-21) 48 (41) 76-13) 98-42-35 (28-70-7) 90-62 (55 (83-20) 49 (42) 77-14) 96-40-33 (26-68-5) 88-60 (53 (81-18) 47 (40) 75-12) 94-38-31 (24-66-3) 86-58 (92-36) 51 (79-16) 45 (38) 73-10 / h29-63H, 22-28H2, 1-21H3 / t29-, 30-, 31-, 32-, 33-, 34-, 35-, 36-, 37-, 38-, 39-, 40-, 41-, 42-, 43+, 44+, 45+, 46+, 47+, 48+, 49+, 50-, 51-, 52-, 53-, 54-, 55-, 56-, 57-, 58-, 59-, 60-, 61-, 62-, 63- / m1 / s1. DSDAICPXUXPBCC-MWD | |
| Heptakis(2,3-di-O-methyl-6-deoxy-6-amino)-beta-cyclodextrin heptahydrochloride | Heptakis(2,3-di-O-methyl-6-deoxy-6-amino)-beta-cyclodextrin heptahydrochloride is a pivotal compound employed sector with ability to study drug solubility and stability. It contributes significantly to enhancing their bioavailability. Molecular formula: C56H112O28N7Cl7. Mole weight: 1579.7. | |
| Heptakis(2,3-di-O-methyl)-hexakis(6-O-methyl)-6-monodeoxy-6-monoamino-beta-cyclodextrin hydrochloride | Heptakis(2,3-di-O-methyl)-hexakis(6-O-methyl)-6-monodeoxy-6-monoamino-beta-cyclodextrin hydrochloride is a novel drug delivery system widely used in the biomedical industry. This product plays a crucial role in enhancing the solubility and stability of various drugs, including those used to treat cancer, infectious diseases, and neurodegenerative disorders. Its unique structure facilitates efficient drug encapsulation, improving therapeutic efficacy while reducing side effects. Molecular formula: C62H112O34NCl. Mole weight: 1451.0. | |
| Methyl-beta-cyclodextrin | 25g Pack Size. Group: Analytical Reagents, Biochemicals, Carbohydrates. Formula: C56H98O35. CAS No. 128446-36-6. Prepack ID 90019033-25g. Molecular Weight 1331.36. See USA prepack pricing. |  |
| Methyl-beta-cyclodextrin | Methyl-beta-cyclodextrin. Group: Macrocycles. CAS No. 128446-36-6. Molecular formula: 1331.36. Mole weight: C56< / sub>H98< / sub>O35< / sub>. | |
| Methyl-beta-cyclodextrin, (mixture of several Methylated) | Methyl-beta-cyclodextrin, (mixture of several Methylated). Group: Macrocycles. CAS No. 128446-36-6. | |
| Methyl-beta-cyclodextrin(mixture of several Methylated) | Methyl-beta-cyclodextrin(mixture of several Methylated). Group: Molecular Biology. CAS No. 128446-36-6. Pack Sizes: 25g, 250g. US Biological Life Sciences. |  Worldwide |
| Methyl Cyclodextrin ; beta-Cyclodextrin methylether | Methyl Cyclodextrin ; beta-Cyclodextrin methylether. Synonyms: MBC; BETA-CYD; BETA-W7 M18; METHYL B-CYCLODEXTRIN; METHYL-SS-CYCLODEXTRIN; Dimethyl-β-Cyclodextrin; METHYL-BETA-CYCLODEXTRIN; B-Cyclodextrin methyl ether; beta-cyclodextrin, methylethers. CAS No. 128446-36-6. Product ID: PE-0588. Molecular formula: C54H94O35. Mole weight: 1303.3. Category: Solubilizing Agents. Product Keywords: Excipients for Liquid Dosage Form; Solubilizer Excipients; PE-0588; Methyl Cyclodextrin ; beta-Cyclodextrin methylether; Solubilizing Agents; C54H94O35; 128446-36-6. UNII: NA. Grade: Pharmceutical Excipients. Source and Preparation: In this paper, methyl-β-cyclodextrin was prepared by using dimethyl sulfate as alkylation reagent. Add 2g sodium hydroxide and 30mL deionized water to a triangular bottle, then add 10g β-cyclodextrin, stir to dissolve. At room temperature, 5mL dimethyl sulfate was slowly added and stirred at the same time. The reaction was heated in a water bath at about 60 °C for 8h. After the reaction, it was cooled and adjusted to neutral with dilute hydrochloric acid. The collection liquid was distilled under vacuum pressure, concentrated to syrupy form, and slowly dropped into 40mL acetone. The product was dispersed into a powdery solid in the acetone. The acetone was filtered out and the product was vacuum dried. Applications: Widely used in pharmaceutical, food, | |
| Mono-6-O-(p-toluenesulfonyl)-beta-cyclodextrin | Mono-6-O-(p-toluenesulfonyl)-beta-cyclodextrin. Group: Macrocycles. Alternative Names: Mono-6-O-(p-toluenesulfonyl)-beta-cyclodextrin; Mono-6-O-Tosyl-beta-Cyclodextrin; β-Cyclodextrin, 6A-(4-methylbenzenesulfonate); mono-(6-p-toluenesulfonyl)-β -cyclodextrin; 6A-(4-methylbenzenesulfonate)- -Cyclodextrin; Mono-6-O-(p-toluenesulfonyl)-&beta. CAS No. 67217-55-4. Molecular formula: 1289.17. Mole weight: C49< / sub>H76< / sub>O37< / sub>S. | |
| PX-316 | PX-316 is a AKT inhibior. PX-316, when administered intraperitoneally to mice at 150 mg/kg, inhibits Akt activation in HT-29 human tumor xenografts up to 78% at 10 h with recovery to 34% at 48 h. PX-316 has antitumor activity against early human MCF-7 breast cancer and HT-29 colon cancer xenografts in mice. PX-316 formulated in 20% hydroxypropyl-beta-cyclodextrin for intravenous administration is well tolerated in mice and rats with no hemolysis and no hematological toxicity. Thus, PX-316 is the lead compound of a new class of potential agents that inhibit Akt survival signaling. Synonyms: PX 316; PX316; D-3-Deoxyphosphatidylinositol Ether Lipid; NSC710297; NSC-710297; Phosphoric acid,2R,3S,4R,6R)-2,3,4,6-tetrahydroxycyclohexyl ester; 1-O-(1-O-Octadecyl-2-O-methyl-L-glycero-3-phospho)-3-deoxy-D-myo-inositol. CAS No. 253440-95-8. Molecular formula: C28H57O10P. Mole weight: 584.73. | |
| Triacetyl-beta-cyclodextrin | Triacetyl-beta-cyclodextrin. Group: Macrocycles. CAS No. 23739-88-0. Product ID: [(1R, 3R, 5R, 6R, 8R, 10R, 11R, 13R, 15R, 16R, 18R, 20R, 21R, 23R, 25R, 26R, 28R, 30R, 31R, 33R, 35R, 36R, 37S, 38R, 39S, 40R, 41S, 42R, 43S, 44R, 45S, 46R, 47S, 48R, 49S)-36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49-tetradecaacetyloxy-10, 15, 20, 25, 30, 35-hexakis(acetyloxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34-tetradecaoxaoctacyclo[31.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31]nonatetracontan-5-yl]methyl acetate. Molecular formula: 2017.8g/mol. Mole weight: C84H112O56. CC (=O)OCC1C2C (C (C (O1)OC3C (OC (C (C3OC (=O)C)OC (=O)C)OC4C (OC (C (C4OC (=O)C)OC (=O)C)OC5C (OC (C (C5OC (=O)C)OC (=O)C)OC6C (OC (C (C6OC (=O)C)OC (=O)C)OC7C (OC (C (C7OC (=O)C)OC (=O)C)OC8C (OC (O2)C (C8OC (=O)C)OC (=O)C)COC (=O)C)COC (=O)C)COC (=O)C)COC (=O)C)COC (=O)C)COC (=O)C)OC (=O)C)OC (=O)C. InChI=1S/C84H112O56/c1-29 (85)106-22-50-57-64 (113-36 (8)92)71 (120-43 (15)99)78 (127-50)135-58-51 (23-107-30 (2)86)129-80 (73 (122-45 (17)101)65 (58)114-37 (9)93)137-60-53 (25-109-32 (4)88)131-82 (75 (124-47 (19)103)67 (60)116-39 (11)95)139-62-55 (27-111-34 (6)90)133-84 (77 (126-49 (21)105)69 (62)118-41 (13)97)140-63-56 (28-112-35 (7)91)132-83 (76 (125-48 (20)104)70 (63)119-42 (14)98)138-61-54 (26-110-33 (5)89)130-81 (74 (123-46 (18)102)68 (61)117-40 (12)96)136-59-52 (24-108-31 (3)87)128-79 (134-57)72 (121-44 (16)100)66 (59)115 | |
Our database is helping our users find suppliers everyday.
